Keyword: Johnson & Johnson

News

J&J Told to Pay $29 Million in Mesothelioma Case

18.03.2019 - A California jury has ordered US healthcare giant Johnson & Johnson to pay $29 million to a woman who claimed her routine use of its talc products caused her mesothelioma, a cancer...

News

Janssen and MeiraGTx Link on Optical Gene Therapy

06.02.2019 - Janssen, the pharmaceuticals arm of Johnson & Johnson, is once again collaborating with US clinical-stage gene therapy company MeiraGTx to develop and commercialize treatments for...

News

Reuters Talc Report Stuns J&J and the Markets

16.12.2018 - Shortly after Environment Canada issued a warning against the use of Johnson & Johnson’s talc-based baby powder, citing health concerns, the publication of a Reuters special report...

News

Canada Warns of Talcum Powder Danger

13.12.2018 - Canada’s environment ministry, Environment Canada, has published a warning on dangers it says are associated with using talcum powder. The talc-containing powder can cause ovarian...

News

J&J to Pay $4.7 Billion in Talc Lawsuit

16.07.2018 - A jury in Missouri, USA, has ordered Johnson & Johnson (J&J) to pay nearly $4.7 billion in damages to 22 women who claimed its talc product had caused them to develop ovarian...

News

J&J wins $55 Million Talc Lawsuit

05.07.2018 - Johnson & Johnson (J&J) has won its third appeal of a verdict implicating its talc-based baby powder in a user’s cancer on a technicality. The Missouri Court of Appeals overturned...

News

J&J Loses Second Mesothelioma Case

29.05.2018 - A jury in the US state of California jury has ruled against Johnson & Johnson in a lawsuit brought by a woman who claimed she developed cancer by using the company's talc-based...

Strategy & Management

Along the Acquisition Trail

17.04.2018 - For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...